ChiRex to supply Glaxo Wellcome with intermediates from former Glaxo plant in Scotland.
Executive Summary
CHIREX TO SUPPLY RANITIDINE INTERMEDIATES TO GLAXO WELLCOME from a former Glaxo plant in Annan, Scotland, under a letter of intent announced July 7. The Annan facility produces pharmaceutical intermediates used in several Glaxo Wellcome products, including Tritec (ranitidine bismuth citrate, called Pylorid in Europe) and Zantac (ranitidine). Under the agreement, ChiRex will purchase the Annan plant but will continue to supply Glaxo Wellcome with the intermediates for at least five years.